MarkNtel Advisors recently published a detailed industry analysis of the Recombinant Proteins Market. The report covers growth trends, regional marketing strategies, challenges, opportunities, and drivers influencing the market.
✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
Insights and Analysis of the Recombinant Proteins Market (2024-2030)
The Global Recombinant Proteins Market size is estimated to grow at a CAGR of around 7.4% during the forecast period, i.e., 2024-30. The increasing incidence of chronic conditions like granulomatous disease, hemophilia, and sclerosis has fueled the growth & expansion of the recombinant protein industry.
Global Recombinant Proteins Market Driver:
The Growing Prevalence of Chronic Diseases Driving Market Growth – The increasing occurrence of conditions like cerebral apoplexy, multiple sclerosis, neutropenia, thrombocytopenia, etc., has been driving the need for recombinant protein drugs. Additionally, treatment methods such as cancer therapy, mammalian cell culture, recombinant protein western blot, recombinant DNA, animal cell culture, glycosylation, biotherapeutics, and bioengineering are witnessing heightened demand, contributing significantly to overall market growth worldwide. In addition, one of the major chronic diseases witnessing rapid growth is cancer. For instance,
In 2022, according to the American Cancer Society’s 2022 statistics, approximately 1,918,030 new cancer cases were estimated in the United States alone for the year.
Access the detailed PDF Sample report – https://www.marknteladvisors.com/query/request-sample/recombinant-proteins-market.html
These increasing occurrences of illnesses among the inhabitants are resulting in the shift towards innovative health treatments. As a result, several non-government organizations are increasingly funding the pharma & bio-pharma companies to develop highly effective drugs. The continuous research & development of high-efficacy drugs would continue to elevate the requirement for recombinant proteins, uplifting the Global Recombinant Proteins Market in the forecast period.
What segments define the Recombinant Proteins market from 2024 to 2030? How do these segments contribute to market dynamics and growth?
-By Product
-Growth Factors and Cytokines- Market Size & Forecast 2019-2030F, USD Billion
-Epidermal Growth Factor (EGF)- Market Size & Forecast 2019-2030F, USD Billion
-Platelet-Derived Growth Factor (PDGF)- Market Size & Forecast 2019-2030F, USD Billion
-Fibroblast Growth Factor (FGF)- Market Size & Forecast 2019-2030F, USD Billion
-Interferons- Market Size & Forecast 2019-2030F, USD Billion
-Interleukins- Market Size & Forecast 2019-2030F, USD Billion
-Others (Vascular Endothelial Growth Factor (VEGF), Transforming Growth Factor-Beta (TGF-β), etc.)
-Antibodies- Market Size & Forecast 2019-2030F, USD Billion
-Immune Checkpoint Proteins- Market Size & Forecast 2019-2030F, USD Billion
-Structural Proteins- Market Size & Forecast 2019-2030F, USD Billion
-Enzymes- Market Size & Forecast 2019-2030F, USD Billion
-Kinases- Market Size & Forecast 2019-2030F, USD Billion
-Hydrolase- Market Size & Forecast 2019-2030F, USD Billion
-Others (Proteases, Lipases, etc.)- Market Size & Forecast 2019-2030F, USD Billion
-Recombinant Regulatory Proteins- Market Size & Forecast 2019-2030F, USD Billion
-Hormones- Market Size & Forecast 2019-2030F, USD Billion
-Others (Membrane Proteins, Adhesion Molecules & Receptors, etc.)- Market Size & Forecast 2019-2030F, USD Billion
-By Host Cells
-Mammalian Cells- Market Size & Forecast 2019-2030F, USD Billion
-Insect Cells- Market Size & Forecast 2019-2030F, USD Billion
-Yeast & Fungi- Market Size & Forecast 2019-2030F, USD Billion
-Bacterial Cells- Market Size & Forecast 2019-2030F, USD Billion
-Others- Market Size & Forecast 2019-2030F, USD Billion
-By Application
-Therapeutics- Market Size & Forecast 2019-2030F, USD Billion
-Biologics- Market Size & Forecast 2019-2030F, USD Billion
-Vaccines- Market Size & Forecast 2019-2030F, USD Billion
-Cell & Gene Therapies- Market Size & Forecast 2019-2030F, USD Billion
-Others (Immunotherapy, Regenerative Medicine, etc.) – Market Size & Forecast 2019-2030F, USD Billion
-Research & Development- Market Size & Forecast 2019-2030F, USD Billion
-Diagnostics- Market Size & Forecast 2019-2030F, USD Billion
-Biotechnology- Market Size & Forecast 2019-2030F, USD Billion
-Others (Industrial, Cosmetics & Personal Care, etc.) – Market Size & Forecast 2019-2030F, USD Billion
-By End Users
-Pharmaceutical & Biopharmaceutical Companies- Market Size & Forecast 2019-2030F, USD Billion
-Research Institutes and Academic Institutions – Market Size & Forecast 2019-2030F, USD Billion
-Diagnostic Laboratories- Market Size & Forecast 2019-2030F, USD Billion
-Others (Contract Research Organizations (CROs), Biotechnology Companies, etc.)- Market Size & Forecast 2019-2030F, USD Billion
Explore the Complete Recombinant Proteins Market Analysis Report – https://www.marknteladvisors.com/research-library/recombinant-proteins-market.html
-By Region
-North America
-South America
-Europe
-Middle East & Africa
-Asia-Pacific
Who are the leading key players shaping the Recombinant Proteins Market landscape?
Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Abcam Limited, Novozymes A/S, GenScript Biotech Corporation, R&D Systems, Inc., ProSpec-Tany TechnoGene Ltd., Cell Signaling Technology, Inc., Enzo Life Sciences, Inc., Sino Biological Inc., Miltenyi Biotec, Abnova Corporation, RayBiotech, Inc., OriGene Technologies, Inc., Others
Questions Addressed in this Study
1.What factors are driving the Recombinant Proteins Market growth?
2.What are the key insights into the current trends in the Recombinant Proteins Market?
3.What is the current size of the Recombinant Proteins Market, and how is it projected to change in the future?
4.What is the future outlook for the Recombinant Proteins Market in terms of technological advancements and market expansion?
For a Customized Analysis Report, Just Drop Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/recombinant-proteins-market.html
“Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.”
Why MarkNtel Advisors?
MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
For Media Inquiries, Please Contact:
Call: +1 628 895 8081 | +91 120 4278433
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
